Keywords
How to Cite
Abstract
Introduction. Currently, in developed countries, virological screening is used as the main screening tool, and the Papanicolaou cytological control service is used as an auxiliary one. For countries with limited financial resources, WHO has recommended various options for an imaging screening strategy called «screening, diagnosis and treatment».
Aim. The choice of the optimal model for the use of cytological studies, economically justified for our country, against the background of the expanding population-based visual screening of cervical cancer.
Material and methods. The data of official statistics and the results of the pilot design of the WHO screening and treatment strategy in the Kushoniyon district of the Khatlon region and B. Gafurov district of the Sughd region were used.
Results. As this study has shown, over the past decades in the Republic of Tajikistan, cytological screening for cervical cancer has fallen into complete decline and in recent years provides only 4.73% of women of reproductive age. Cytological examinations of cervical smears in the country are performed only as an additional test in cases of suspected cervical intraepithelial neoplasia. Due to the existing economic problems in the country, since 2016, the visual screening recommended by WHO for countries with limited resources has been introduced in a pilot way. The first results of the pilot implementation of visual screening have shown its high efficiency at a low economic cost. However, the question of the role of cytological studies against the background of coverage of the population with visual screening remains unclear. The economic feasibility and scale of the reorganization of cytomorphological support for cervical cancer screening in the Republic of Tajikistan was confirmed.
Conclusions. In the conditions of the Republic of Tajikistan, as a result of the widespread coverage of the population with visual screening, Papanicolaou cytological studies will serve as an auxiliary tool and can be reorganized on the basis of the Republican Cancer Research Center and its regional and interdistrict divisions.
References
Национальная стратегия здоровья населения Республики Таджикистан на период до 2030 г.: утвержден Постановлением Правительства Республики Таджикистан 30.09.2021, № 414, г. Душанбе. [National health strategy of the population of the Republic of Tajikistan for the period up to 2030: approved by the Decree of the Government of the Republic of Tajikistan on September 30, 2021, № 414, Dushanbe (In Russ.)].
Всемирная организация здравоохранения. Вирус папилломы человека и рак шейки матки // ВОЗ, 2019 г. [World Health Organization. Human papillomavirus and cervical cancer // WHO. 2019 (In Russ.)]. doi:www.who.int/ru/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
WHO guidelines for treatment of cervical intraepithelial neoplasia 2–3 and glandular adenocarcinoma in situ: Cryotherapy, large loop excision of the transformation zone (LEEP/ LLETZ), and cold knife conization. Geneva, World Health Organization. 2014.
WHO cervical cancer prevention and control costing tool (C4P). Geneva, World Health Organization. 2012. doi:www.who.int/nuvi/hpv/cervical_cancer_costing_tool/en/index.html, accessed 24 October 2013.
Всемирная организация здравоохранения. Комплексная борьба с раком шейки матки, 2-е издание. 2014 г. // ВОЗ, 2018 г. [World Health Organization. Integrated control of cervical cancer, 2nd edition. 2014 // WHO, 2018 (In Russ.)]. doi:www.euro.who.int/__data/assets/pdf_file/0007/383452/c4gep-rus.pdf
Здоровье населения и деятельность учреждений здравоохранения в 2019 г.: Государственное учреждение республиканский центр статистики и медицинской информации Министерства здравоохранения и социальной защиты населения Республики Таджикистан. Душанбе, 2020:368 [Health of the population and the activities of health care institutions in 2019: State institution republican center for statistics and medical information of the Ministry of Health and Social Protection of the Population of the Republic of Tajikistan. Dushanbe, 2020:368 (In Russ.)].
Актанко А.П., Бойцова Т.Ю., Климкович Н.М. Результаты цитологического скрининга мазков-отпечатков шейки матки как маркера интраэпителиальных патологических изменений // Здравоохранение Дальнего Востока. 2018;2:51-54 [Aktanko AP, Boytsova TYu, Klimkovich NM. Results of cytological screening of cervical smears as a marker of intraepithelial pathological changes // Healthcare of the Far East. 2018;2:51–54 (In Russ.)].
Белорусско-итальянский пилотный проект по скринингу рака шейки матки // Республика Беларусь. Минск, 2018 [Belarusian-Italian pilot project for cervical cancer screening // Republic of Belarus. Minsk, 2018 (In Russ.)]. doi:www.belta.by/regions/view/belorussko-italjjanskij-pilotnyj-proekt-po-skriningu-raka-shejki-matki-realizuetsja-v-gomelskoj-oblasti-302630-2018/
Цхай В.Б., Круглова Д.Ю., Савченко А.А. Эффективность цитологического скрининга и вакцинации против вируса папилломы человека в профилактике рака шейки матки // Сибирское медицинское обозрение. 2011;3:8–13 [Tskhai VB, Kruglova DYu, Savchenko AA. The effectiveness of cytological screening and vaccination against human papillomavirus in the prevention of cervical cancer // Siberian Medical Review. 2011;3:8–13 (In Russ.)].
Nasser SM, Cibas ES, Crum CP, Faquin WC. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion // Cancer. 2003;99(5):272–6.
Дэвис Ф. Разработка национальных планов программ организованного скрининга на рак шейки матки в странах Восточной Европы и Центральной Азии // Фонд народонаселения ООН и Европейская ассоциация онкологического совета. 10.11.2015 [Davis F. Development of national plans for organized screening programs for cervical cancer in Eastern Europe and Central Asia // UN Population Fund and European Association of Cancer Council. 10.11.2015 (In Russ.)].
Daiva Vaitkiene. Mission report on situation analyses and needs assessment on prevention of cervical cancer in Tajikistan // Dushanbe, Tajikistan. 2012:12.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2022